NASDAQ: AVTE - Aerovate Therapeutics, Inc.

Lønnsomhet i seks måneder: -90.43%
Sektor: Healthcare

Kampanjeplan Aerovate Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Цена ао 25.65
EBITDA -0.0033
Число акций ао 0.02633 млрд
P/BV 1.67
EV/EBITDA 0.3045
ISIN US0080641071
Сайт https://aerovatetx.com
Валюта usd
IPO date 2021-06-30
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Prisendring per dag: 0% (2.11)
Prisendring per uke: +3.43% (2.04)
Prisendring per måned: +11.05% (1.9)
Prisendring over 3 måneder: +15.93% (1.82)
Prisendring over seks måneder: -90.43% (22.05)
Prisendring per år: -81.43% (11.36)
Prisendring over 3 år: -88.9% (19.01)
Prisendring siden begynnelsen av året: -86.19% (15.28)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 5.58 2
P/E 0 0
EV/EBITDA -7.23 0
Total: 2.25

Effektivitet

Navn Betydning Karakter
ROA, % -59.27 0
ROE, % -69 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0083 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 2364.03 10
Lønnsomhet EPS, % 104.86 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
RA Capital Management, L.P. 8263982 29.66
Sofinnova Investments, Inc. 3758686 13.49
Tcg Crossover Management, Llc 2201274 7.9
Atlas Venture Life Science Advisors, LLC 2039249 7.32
Baker Brothers Advisors, LLC 1680517 6.03
Cormorant Asset Management, LP 1211696 4.35
Frazier Life Sciences Management, L.P. 1204867 4.32
Driehaus Capital Management, LLC 1058209 3.8
Great Point Partners LLC 1037690 3.72
Orbimed Advisors LLC. 756930 2.72

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Virtus LifeSci Biotech Clinical Trials ETF 0.06121 63.040315712071 0.33
ProShares Hedge Replication ETF 0.00016 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.00658 34.327031588619 1.54048
iShares Russell 2000 Growth ETF 0.00201 38.042556988 0.6026
iShares Russell 3000 ETF 0.00006 31.230028873917 1.43482
ProShares UltraPro Russell2000 0.00055 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0 32.773459189339 1.48801



Veileder Stillingstittel Betaling Fødselsår
Mr. Timothy P. Noyes M.B.A. CEO & Director 936.9k 1962 (62 år)
Mr. George A. Eldridge CFO & Treasurer 658.6k 1963 (61 år)
Dr. Marinus Verwijs Ph.D. Chief Technical Officer 439.88k 1976 (48 år)
Dr. Benjamin T. Dake Ph.D. Founder, President, COO & Secretary 435.5k 1976 (48 år)
Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S Chief Scientific Officer 372.33k 1960 (64 år)
Mr. Hunter Gillies M.D. Chief Medical Officer 512.74k 1966 (58 år)
Mr. Timothy J. Pigot Chief Commercial Officer 584.6k 1971 (53 år)
Ms. Donna Dea Head of Regulatory Affairs N/A
Ms. Susan Fischer Executive Vice President of Development Operations N/A
Mr. Stephen K. Yu Senior Vice President of Quality N/A

Adresse: United States, Waltham. MA, 930 Winter Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://aerovatetx.com